Resolute Wealth Strategies’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Resolute Wealth Strategies’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,327	Closed	-$226K	–	103
2025 Q1	$226K	Hold	1,327	–	–	0.13%	94
2024 Q4	$221K	Sell	1,327 -18	-1%	-$3.08K	0.11%	89
2024 Q3	$231K	Sell	1,345 -75	-5%	-$12.4K	0.12%	89
2024 Q2	$219K	Sell	1,420 -140	-9%	-$21K	0.13%	87
2024 Q1	$240K	Hold	1,560	–	–	0.15%	84
2023 Q4	$247K	Sell	1,560 -103	-6%	-$14.8K	0.17%	79
2023 Q3	$243K	Sell	1,663 -10	-0.6%	-$1.52K	0.18%	73
2023 Q2	$256K	Hold	1,673	–	–	0.2%	74
2023 Q1	$259K	Buy	+1,673	New	+$263K	0.22%	71

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Resolute Wealth Strategies's FBT Position: Q2 2025 in Review

Resolute Wealth Strategies sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2025, closing a stake of 1,327 shares — an estimated $226K sold.

Resolute Wealth Strategies first reported a position in FBT in Q1 2023 and held it in 9 quarters. The position peaked at $259K in Q1 2023. 250 funds tracked by Wall St. Rank hold FBT as of Q2 2025.

Resolute Wealth Strategies reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2025 after selling out during the quarter.
Resolute Wealth Strategies sold 1,327 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2025, an estimated $226K.
Resolute Wealth Strategies first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2023 and held it in 9 quarters.
Resolute Wealth Strategies's First Trust NYSE Arca Biotechnology Index Fund position peaked at $259K in Q1 2023.
250 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2025.

Based on Resolute Wealth Strategies's 13F filing for Q2 2025, filed 12 Aug 2025.